XML 57 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock Outstanding
Treasury Shares at Cost
Par Value and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2017 $ 22,559   $ (4) $ 38,629 $ 8 $ (16,074)
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2017   859,406,651        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,248         2,248
Other comprehensive (loss) income 0          
Stock-based compensation 361     361    
Exercise of stock options 3     3    
Exercise of stock options (in shares)   174,514        
Stock issued for employee stock purchase plan 103     103    
Stock issued for employee stock purchase plan (in shares)   2,011,970        
Issuance of vested restricted stock units (in shares)   4,707,512        
Issuance of restricted stock awards (in shares)   354,459        
Shares withheld related to net share settlement of stock awards and stock options (89)     (89)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,481,129)        
Repurchases of common stock (1,054)     (1,054)    
Repurchases of common stock (in shares)   (16,738,758)        
Transfer RSU from NQDC plan     (3) 3    
Transfer RSU to NQDC plan (in shares)   (54,540)        
Prior year retained earnings 224       (8) 232
Balance, end of period at Sep. 30, 2018 24,355   (7) 37,956 0 (13,594)
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2018   848,380,679        
Balance, beginning of period at Jun. 30, 2018 23,390   (7) 37,786 0 (14,389)
Common stock, shares outstanding, beginning (in shares) at Jun. 30, 2018   847,225,746        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 795         795
Other comprehensive (loss) income 0          
Stock-based compensation 127     127    
Exercise of stock options 0     0    
Exercise of stock options (in shares)   36,973        
Stock issued for employee stock purchase plan 48     48    
Stock issued for employee stock purchase plan (in shares)   942,475        
Issuance of vested restricted stock units (in shares)   251,953        
Shares withheld related to net share settlement of stock awards and stock options $ (5)     (5)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (77,323)        
Distribution from NQDC plan (in shares) 855          
Balance, end of period at Sep. 30, 2018 $ 24,355   (7) 37,956 0 (13,594)
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2018   848,380,679        
Balance, beginning of period at Dec. 31, 2018 $ 24,718   (6) 38,010 (332) (12,954)
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2018 850,180,317 850,180,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 2,717         2,717
Other comprehensive (loss) income (738)       (738)  
Stock-based compensation 404     404    
Exercise of stock options 1     1    
Exercise of stock options (in shares)   70,754        
Stock issued for employee stock purchase plan 124     124    
Stock issued for employee stock purchase plan (in shares)   2,091,650        
Issuance of vested restricted stock units (in shares)   4,729,270        
Forfeiture of restricted stock awards (in shares)   (20,769)        
Shares withheld related to net share settlement of stock awards and stock options (108)     (108)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,474,011)        
Transfer RSU from NQDC plan     (2) 2    
Transfer RSU to NQDC plan (in shares)   (19,540)        
Prior year retained earnings 653         653
Balance, end of period at Sep. 30, 2019 $ 27,771   (8) 38,433 (1,070) (9,584)
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2019 855,557,671 855,557,671        
Balance, beginning of period at Jun. 30, 2019 $ 26,967   (8) 38,242 (813) (10,454)
Common stock, shares outstanding, beginning (in shares) at Jun. 30, 2019   854,452,642        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 870         870
Other comprehensive (loss) income (257)       (257)  
Stock-based compensation 140     140    
Exercise of stock options (in shares)   19,619        
Stock issued for employee stock purchase plan 55     55    
Stock issued for employee stock purchase plan (in shares)   955,849        
Issuance of vested restricted stock units (in shares)   179,155        
Shares withheld related to net share settlement of stock awards and stock options (4)     (4)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (53,349)        
Distribution from NQDC plan (in shares)   3,755        
Balance, end of period at Sep. 30, 2019 $ 27,771   $ (8) $ 38,433 $ (1,070) $ (9,584)
Common stock, shares outstanding, ending (in shares) at Sep. 30, 2019 855,557,671 855,557,671